We are live on
!
Find out more
RC
Rovin Capital Portfolio holdings
AUM
$377M
1-Year Est. Return
13.67%
This Fund
S&P 500
This Quarter
Est. Return
+6.54%
1 Year Est. Return
+13.67%
3 Year Est. Return
+63.79%
5 Year Est. Return
+64.65%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$62.3M
(+43%)
Cap. Flow
+$52M
Cap. Flow
% of AUM
24.98%
Top 10 Holdings %
Top 10 Hldgs %
58.39%
Holding
122
New
55
Increased
36
Reduced
19
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$11.4M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$10M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$7.9M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.24M |
| 5 |
Innovator US Equity Buffer ETF September
BSEP
|
+$3.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$7.84M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$6.02M |
| 3 |
SCHV
Schwab US Large-Cap Value ETF
SCHV
|
+$3.36M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$2.84M |
| 5 |
Vanguard Mid-Cap Value ETF
VOE
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.29% |
| 2 | Technology | 4.52% |
| 3 | Consumer Staples | 1.66% |
| 4 | Industrials | 1.58% |
| 5 | Financials | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Thermo Fisher Scientific
TMO
$214B
| $641K | 0.31% |
961
+603
| +168% | +$376K |
|
52
Innovator US Equity Buffer ETF January
BJAN
$343M
| $640K | 0.31% |
+17,163
| New | +$634K |
|
53
iShares Core Dividend Growth ETF
DGRO
$43.3B
| $628K | 0.3% |
11,308
+891
| +9% | +$47.5K |
|
54
Berkshire Hathaway Class B
BRK.B
$1.11T
| $627K | 0.3% |
+2,096
| New | +$600K |
|
55
Philip Morris
PM
$312B
| $620K | 0.3% |
+6,530
| New | +$610K |
|
56
Corteva
CTVA
$59.5B
| $616K | 0.3% |
+13,039
| New | +$594K |
|
57
Salesforce
CRM
$149B
| $613K | 0.29% |
+2,412
| New | +$678K |
|
58
Dominion Energy
D
$62.1B
| $613K | 0.29% |
+7,801
| New | +$587K |
|
59
Blackbaud
BLKB
$1.65B
| $611K | 0.29% |
+7,737
| New | +$598K |
|
60
Janus Henderson Short Duration Income ETF
VNLA
$3.33B
| $602K | 0.29% |
12,142
-245
| -2% | -$12.2K |
|
61
Pfizer
PFE
$144B
| $601K | 0.29% |
+10,184
| New | +$505K |
|
62
Medtronic
MDT
$111B
| $583K | 0.28% |
+5,633
| New | +$652K |
|
|
K
63
DELISTED
Kellanova
K
| $582K | 0.28% |
+9,630
| New | +$568K |
|
64
Meta Platforms (Facebook)
META
$1.51T
| $574K | 0.28% |
+1,708
| New | +$567K |
|
65
iShares MSCI ACWI ETF
ACWI
$32.5B
| $571K | 0.27% |
5,402
-44
| -0.8% | -$4.6K |
|
66
Boeing
BA
$175B
| $558K | 0.27% |
+2,770
| New | +$585K |
|
67
Guidewire Software
GWRE
$13.3B
| $545K | 0.26% |
+4,801
| New | +$569K |
|
68
Polaris
PII
$4.07B
| $522K | 0.25% |
+4,748
| New | +$559K |
|
69
iShares Core MSCI Emerging Markets ETF
IEMG
$147B
| $511K | 0.25% |
8,538
-761
| -8% | -$47K |
|
70
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
| $505K | 0.24% |
976
-8
| -0.8% | -$4.07K |
|
71
Compass Minerals
CMP
$1.25B
| $486K | 0.23% |
+9,522
| New | +$581K |
|
72
Zimmer Biomet
ZBH
$18.5B
| $467K | 0.22% |
+3,789
| New | +$496K |
|
73
iShares MSCI Intl Quality Factor ETF
IQLT
$13.7B
| $458K | 0.22% |
11,630
+2,613
| +29% | +$102K |
|
74
JPMorgan Chase
JPM
$950B
| $454K | 0.22% |
2,869
| – | – |
|
75
FT Vest Buffered Allocation Growth ETF
BUFG
$325M
| $446K | 0.21% |
+21,973
| New | +$442K |
|
Similar funds
PWM
EP
RPCA
DP
PPL
MWM
LODC
AWIRL
Rovin Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Rovin Capital held 122 positions worth $208M, up 43% from $146M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Rovin Capital deployed $52M of net new capital in Q4 2021, opening 55 new positions and adding to 36 existing holdings. Its largest new stake was Innovator US Equity Buffer ETF September: 115,156 shares worth $3.85M.
By sector, the portfolio is most concentrated in Healthcare at 5.3% of assets, up from 4.3% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Vanguard Mid-Cap Value ETF, an estimated $1.95M trimmed.
- Rovin Capital's largest Q4 2021 buy was Innovator US Equity Buffer ETF September: 115,156 shares worth $3.85M.
- Rovin Capital added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q4 2021, an estimated $11.4M increase.
- Rovin Capital's biggest Q4 2021 reduction was Vanguard Mid-Cap Value ETF, cutting an estimated $1.95M.
- Rovin Capital fully exited State Street SPDR Bloomberg High Yield Bond ETF in Q4 2021, selling an estimated $7.84M.
- Rovin Capital's ten largest holdings make up 58% of its $208M portfolio in Q4 2021.
- Rovin Capital opened 55 new positions and closed 7 in Q4 2021.
- Rovin Capital's portfolio value rose 43% quarter-over-quarter to $208M.
Based on Rovin Capital's 13F filing for Q4 2021, filed 24 Feb 2022.